Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey
Emmanuelle A. D. Schindler, Christopher Gottschalk, Marsha J. Weil, Robert E. Shapiro, Douglas A. Wright, R. Andrew Sewell
Journal of Psychoactive Drugs October 20, 2015 DOI: 10.1080/02791072.2015.1107664 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 496 |
| Population | People with cluster headache |
| Interventions | Psilocybin Lysergic acid diethylamide Lysergic acid amide |
| Topics | Ayahuasca LSD Psilocybin |
| Keywords | Hallucinogen Cluster headache Cluster spacecraft Dissociative |
| Citations | 104 |
| Key findings | Indoleamine hallucinogens were rated as comparable to or more efficacious than most conventional medications for treating cluster headache, including shortening or aborting cluster periods and inducing remission in chronic cases. |
Abstract
Cluster headache is one of the most debilitating pain syndromes. A significant number of patients are refractory to conventional therapies. The Clusterbusters.org medication use survey sought to characterize the effects of both conventional and alternative medications used in cluster headache. Participants were recruited from cluster headache websites and headache clinics. The final analysis included responses from 496 participants. The survey was modeled after previously published surveys and was available online. Most responses were chosen from a list, though others were free-texted. Conventional abortive and preventative medications were identified and their efficacies agreed with those previously published. The indoleamine hallucinogens, psilocybin, lysergic acid diethylamide, and lysergic acid amide, were comparable to or more efficacious than most conventional medications. These agents were also perceived to shorten/abort a cluster period and bring chronic cluster headache into remission more so than conventional medications. Furthermore, infrequent and non-hallucinogenic doses were reported to be efficacious. Findings provide additional evidence that several indoleamine hallucinogens are rated as effective in treating cluster headache. These data reinforce the need for further investigation of the effects of these and related compounds in cluster headache under experimentally controlled settings.
Comparable studies
Other cross-sectional and survey studies on ayahuasca, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT Adults reporting a single most memorable God encounter experience, either nondrug or... | 2019 | Cross-sectional survey | n = 4,285 |
| Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. Ayahuasca users from more than 50 countries who completed an online survey | 2022 | Cross-sectional survey | n = 10,836 |
| Ayahuasca in adolescence: a preliminary psychiatric assessment. Adolescents from a Brazilian ayahuasca sect and matched controls | 2005 | Controlled cross-sectional study | n = 80 |
| Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls | 2016 | Cross-sectional study | n = 57 |
| Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca Brazilian members of União do Vegetal (UDV) aged 18 and older | 2018 | Observational cross-sectional study with normative comparison | n = 1,947 |
Citations in the library
Cited by 81
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology June 5, 2018
- Potential Therapeutic Effects of Psilocybin. Neurotherapeutics July 1, 2017
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Modern Clinical Research on LSD Neuropsychopharmacology April 27, 2017
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
and 76 more in the library
Cites 10
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Journal of Psychopharmacology March 8, 2012
- The pharmacology of psilocybin Addiction Biology October 1, 2002
and 5 more in the library